Quicksilver Scientific

Dr. Shade's Bitters No. 9

F
N+ Score28
Vitamins & MineralsServing: 1 mLType: Botanical with Nutrients

Dr. Shade's Bitters No. 9 by Quicksilver Scientific is classified as a Botanical with Nutrients supplement, featuring a total of two ingredients. The product includes 40 mg of Phosphatidylcholine, which our analysis indicates is present at an underdosed level, and a 271 mg Proprietary Blend. This supplement received an N+ Score of 28, earning an 'F' grade, placing it in the 'poor' tier. The low score reflects an ingredient adequacy of 0% and formula completeness of 0%, suggesting the product may not deliver on its potential. While label transparency is 100%, the overall formulation does not align with research-backed dosages for its active components. This product might be considered by individuals exploring botanical blends, but its low N+ Score suggests limited efficacy based on current scientific understanding.

About This Product

Dr. Shade's Bitters No. 9 by Quicksilver Scientific is a vitamins & minerals supplement containing 2 active ingredients. It has earned an N+ Score of 28/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity42/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Several ingredients below clinically effective doses
  • Missing several expected ingredients for its category

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Proprietary Blend271.000 mgN/A
Phosphatidylcholine40.000 mgUnder

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.